nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—Naftifine—Tamoxifen—pancreatic cancer	0.753	1	CrCrCtD
Naphazoline—Accidental exposure to product—Tamoxifen—pancreatic cancer	0.0325	0.198	CcSEcCtD
Naphazoline—Accidental ingestion—Tamoxifen—pancreatic cancer	0.0325	0.198	CcSEcCtD
Naphazoline—NISCH—Paclitaxel—Docetaxel—pancreatic cancer	0.00808	1	CbGdCrCtD
Naphazoline—Keratitis—Erlotinib—pancreatic cancer	0.00468	0.0285	CcSEcCtD
Naphazoline—Redness—Tamoxifen—pancreatic cancer	0.00454	0.0276	CcSEcCtD
Naphazoline—Lacrimation—Irinotecan—pancreatic cancer	0.00368	0.0224	CcSEcCtD
Naphazoline—Lacrimation—Fluorouracil—pancreatic cancer	0.00352	0.0214	CcSEcCtD
Naphazoline—Lacrimation increased—Sunitinib—pancreatic cancer	0.00285	0.0173	CcSEcCtD
Naphazoline—Lacrimation—Docetaxel—pancreatic cancer	0.00254	0.0155	CcSEcCtD
Naphazoline—Lacrimation increased—Irinotecan—pancreatic cancer	0.00235	0.0143	CcSEcCtD
Naphazoline—Lacrimation increased—Fluorouracil—pancreatic cancer	0.00225	0.0137	CcSEcCtD
Naphazoline—Redness—Docetaxel—pancreatic cancer	0.00221	0.0135	CcSEcCtD
Naphazoline—Lacrimation—Epirubicin—pancreatic cancer	0.00171	0.0104	CcSEcCtD
Naphazoline—Sweating—Tamoxifen—pancreatic cancer	0.00164	0.01	CcSEcCtD
Naphazoline—Lacrimation increased—Docetaxel—pancreatic cancer	0.00162	0.00987	CcSEcCtD
Naphazoline—Lacrimation—Doxorubicin—pancreatic cancer	0.00159	0.00966	CcSEcCtD
Naphazoline—Keratitis—Epirubicin—pancreatic cancer	0.00155	0.00946	CcSEcCtD
Naphazoline—Redness—Epirubicin—pancreatic cancer	0.00149	0.00909	CcSEcCtD
Naphazoline—Hyperglycaemia—Sunitinib—pancreatic cancer	0.00149	0.00904	CcSEcCtD
Naphazoline—Keratitis—Doxorubicin—pancreatic cancer	0.00144	0.00875	CcSEcCtD
Naphazoline—Eye disorder—Erlotinib—pancreatic cancer	0.00142	0.00866	CcSEcCtD
Naphazoline—Redness—Doxorubicin—pancreatic cancer	0.00138	0.00841	CcSEcCtD
Naphazoline—Erythema—Tamoxifen—pancreatic cancer	0.00134	0.00815	CcSEcCtD
Naphazoline—Erythema—Erlotinib—pancreatic cancer	0.00133	0.00807	CcSEcCtD
Naphazoline—Eye disorder—Sunitinib—pancreatic cancer	0.00123	0.0075	CcSEcCtD
Naphazoline—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.00119	0.00726	CcSEcCtD
Naphazoline—Sweating—Irinotecan—pancreatic cancer	0.00116	0.00706	CcSEcCtD
Naphazoline—Hypertension—Tamoxifen—pancreatic cancer	0.00116	0.00704	CcSEcCtD
Naphazoline—Erythema—Sunitinib—pancreatic cancer	0.00115	0.00698	CcSEcCtD
Naphazoline—Sweating—Gemcitabine—pancreatic cancer	0.00113	0.00688	CcSEcCtD
Naphazoline—Discomfort—Tamoxifen—pancreatic cancer	0.00113	0.00686	CcSEcCtD
Naphazoline—Lacrimation increased—Epirubicin—pancreatic cancer	0.00109	0.00666	CcSEcCtD
Naphazoline—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00106	0.00643	CcSEcCtD
Naphazoline—Lacrimation increased—Doxorubicin—pancreatic cancer	0.00101	0.00616	CcSEcCtD
Naphazoline—Hypertension—Sunitinib—pancreatic cancer	0.000991	0.00603	CcSEcCtD
Naphazoline—Erythema—Gemcitabine—pancreatic cancer	0.000921	0.0056	CcSEcCtD
Naphazoline—Erythema—Fluorouracil—pancreatic cancer	0.000905	0.00551	CcSEcCtD
Naphazoline—Vision blurred—Fluorouracil—pancreatic cancer	0.000853	0.00519	CcSEcCtD
Naphazoline—Hypertension—Irinotecan—pancreatic cancer	0.000816	0.00497	CcSEcCtD
Naphazoline—Eye pain—Epirubicin—pancreatic cancer	0.000811	0.00493	CcSEcCtD
Naphazoline—Discomfort—Irinotecan—pancreatic cancer	0.000795	0.00484	CcSEcCtD
Naphazoline—Hypertension—Gemcitabine—pancreatic cancer	0.000795	0.00484	CcSEcCtD
Naphazoline—Asthenia—Tamoxifen—pancreatic cancer	0.000785	0.00478	CcSEcCtD
Naphazoline—Asthenia—Erlotinib—pancreatic cancer	0.000776	0.00472	CcSEcCtD
Naphazoline—Discomfort—Gemcitabine—pancreatic cancer	0.000775	0.00471	CcSEcCtD
Naphazoline—Discomfort—Fluorouracil—pancreatic cancer	0.000762	0.00463	CcSEcCtD
Naphazoline—Eye pain—Doxorubicin—pancreatic cancer	0.00075	0.00457	CcSEcCtD
Naphazoline—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000746	0.00454	CcSEcCtD
Naphazoline—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000727	0.00442	CcSEcCtD
Naphazoline—Dizziness—Tamoxifen—pancreatic cancer	0.000723	0.0044	CcSEcCtD
Naphazoline—Dizziness—Erlotinib—pancreatic cancer	0.000715	0.00435	CcSEcCtD
Naphazoline—Eye disorder—Docetaxel—pancreatic cancer	0.000702	0.00427	CcSEcCtD
Naphazoline—Somnolence—Irinotecan—pancreatic cancer	0.000686	0.00417	CcSEcCtD
Naphazoline—Headache—Tamoxifen—pancreatic cancer	0.000685	0.00417	CcSEcCtD
Naphazoline—Headache—Erlotinib—pancreatic cancer	0.000678	0.00413	CcSEcCtD
Naphazoline—Asthenia—Sunitinib—pancreatic cancer	0.000672	0.00409	CcSEcCtD
Naphazoline—Somnolence—Gemcitabine—pancreatic cancer	0.000668	0.00407	CcSEcCtD
Naphazoline—Somnolence—Fluorouracil—pancreatic cancer	0.000657	0.004	CcSEcCtD
Naphazoline—Erythema—Docetaxel—pancreatic cancer	0.000653	0.00398	CcSEcCtD
Naphazoline—Nausea—Tamoxifen—pancreatic cancer	0.00065	0.00395	CcSEcCtD
Naphazoline—Nausea—Erlotinib—pancreatic cancer	0.000643	0.00391	CcSEcCtD
Naphazoline—Dizziness—Sunitinib—pancreatic cancer	0.000619	0.00377	CcSEcCtD
Naphazoline—Headache—Sunitinib—pancreatic cancer	0.000587	0.00357	CcSEcCtD
Naphazoline—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000571	0.00347	CcSEcCtD
Naphazoline—Hypertension—Docetaxel—pancreatic cancer	0.000564	0.00343	CcSEcCtD
Naphazoline—Drowsiness—Epirubicin—pancreatic cancer	0.000564	0.00343	CcSEcCtD
Naphazoline—Nausea—Sunitinib—pancreatic cancer	0.000556	0.00339	CcSEcCtD
Naphazoline—Asthenia—Irinotecan—pancreatic cancer	0.000554	0.00337	CcSEcCtD
Naphazoline—Sweating—Epirubicin—pancreatic cancer	0.000541	0.00329	CcSEcCtD
Naphazoline—Asthenia—Gemcitabine—pancreatic cancer	0.000539	0.00328	CcSEcCtD
Naphazoline—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000528	0.00321	CcSEcCtD
Naphazoline—Drowsiness—Doxorubicin—pancreatic cancer	0.000522	0.00318	CcSEcCtD
Naphazoline—Dizziness—Irinotecan—pancreatic cancer	0.00051	0.00311	CcSEcCtD
Naphazoline—Sweating—Doxorubicin—pancreatic cancer	0.0005	0.00304	CcSEcCtD
Naphazoline—Dizziness—Fluorouracil—pancreatic cancer	0.000489	0.00297	CcSEcCtD
Naphazoline—Headache—Irinotecan—pancreatic cancer	0.000483	0.00294	CcSEcCtD
Naphazoline—Somnolence—Docetaxel—pancreatic cancer	0.000474	0.00289	CcSEcCtD
Naphazoline—Eye disorder—Epirubicin—pancreatic cancer	0.000473	0.00288	CcSEcCtD
Naphazoline—Headache—Gemcitabine—pancreatic cancer	0.000471	0.00287	CcSEcCtD
Naphazoline—Headache—Fluorouracil—pancreatic cancer	0.000463	0.00282	CcSEcCtD
Naphazoline—Nausea—Irinotecan—pancreatic cancer	0.000458	0.00279	CcSEcCtD
Naphazoline—Nausea—Gemcitabine—pancreatic cancer	0.000446	0.00272	CcSEcCtD
Naphazoline—Erythema—Epirubicin—pancreatic cancer	0.000441	0.00268	CcSEcCtD
Naphazoline—Nausea—Fluorouracil—pancreatic cancer	0.000439	0.00267	CcSEcCtD
Naphazoline—Eye disorder—Doxorubicin—pancreatic cancer	0.000438	0.00266	CcSEcCtD
Naphazoline—Tension—Epirubicin—pancreatic cancer	0.000433	0.00263	CcSEcCtD
Naphazoline—Nervousness—Epirubicin—pancreatic cancer	0.000428	0.00261	CcSEcCtD
Naphazoline—Vision blurred—Epirubicin—pancreatic cancer	0.000415	0.00253	CcSEcCtD
Naphazoline—Erythema—Doxorubicin—pancreatic cancer	0.000408	0.00248	CcSEcCtD
Naphazoline—Tension—Doxorubicin—pancreatic cancer	0.0004	0.00244	CcSEcCtD
Naphazoline—Nervousness—Doxorubicin—pancreatic cancer	0.000396	0.00241	CcSEcCtD
Naphazoline—Vision blurred—Doxorubicin—pancreatic cancer	0.000384	0.00234	CcSEcCtD
Naphazoline—Asthenia—Docetaxel—pancreatic cancer	0.000383	0.00233	CcSEcCtD
Naphazoline—Hypertension—Epirubicin—pancreatic cancer	0.000381	0.00232	CcSEcCtD
Naphazoline—Discomfort—Epirubicin—pancreatic cancer	0.000371	0.00226	CcSEcCtD
Naphazoline—Dizziness—Docetaxel—pancreatic cancer	0.000353	0.00215	CcSEcCtD
Naphazoline—Hypertension—Doxorubicin—pancreatic cancer	0.000352	0.00214	CcSEcCtD
Naphazoline—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000348	0.00212	CcSEcCtD
Naphazoline—Discomfort—Doxorubicin—pancreatic cancer	0.000343	0.00209	CcSEcCtD
Naphazoline—Headache—Docetaxel—pancreatic cancer	0.000334	0.00203	CcSEcCtD
Naphazoline—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000322	0.00196	CcSEcCtD
Naphazoline—Somnolence—Epirubicin—pancreatic cancer	0.00032	0.00195	CcSEcCtD
Naphazoline—Nausea—Docetaxel—pancreatic cancer	0.000317	0.00193	CcSEcCtD
Naphazoline—Somnolence—Doxorubicin—pancreatic cancer	0.000296	0.0018	CcSEcCtD
Naphazoline—Asthenia—Epirubicin—pancreatic cancer	0.000258	0.00157	CcSEcCtD
Naphazoline—Asthenia—Doxorubicin—pancreatic cancer	0.000239	0.00145	CcSEcCtD
Naphazoline—Dizziness—Epirubicin—pancreatic cancer	0.000238	0.00145	CcSEcCtD
Naphazoline—Headache—Epirubicin—pancreatic cancer	0.000225	0.00137	CcSEcCtD
Naphazoline—Dizziness—Doxorubicin—pancreatic cancer	0.00022	0.00134	CcSEcCtD
Naphazoline—Nausea—Epirubicin—pancreatic cancer	0.000214	0.0013	CcSEcCtD
Naphazoline—Headache—Doxorubicin—pancreatic cancer	0.000209	0.00127	CcSEcCtD
Naphazoline—Nausea—Doxorubicin—pancreatic cancer	0.000198	0.0012	CcSEcCtD
Naphazoline—ADRA2C—Hemostasis—NRAS—pancreatic cancer	3.13e-05	0.000419	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—TGFB1—pancreatic cancer	3.11e-05	0.000417	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AGTR1—pancreatic cancer	3.09e-05	0.000414	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CD44—pancreatic cancer	3.07e-05	0.00041	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—STK11—pancreatic cancer	3.05e-05	0.000408	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PIK3CG—pancreatic cancer	3.04e-05	0.000407	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—GCG—pancreatic cancer	3.03e-05	0.000405	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PTHLH—pancreatic cancer	3.02e-05	0.000403	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PTCH1—pancreatic cancer	3.02e-05	0.000403	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SST—pancreatic cancer	2.97e-05	0.000397	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.94e-05	0.000394	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GCG—pancreatic cancer	2.94e-05	0.000393	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.93e-05	0.000392	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—TYMS—pancreatic cancer	2.93e-05	0.000392	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—TGFB1—pancreatic cancer	2.91e-05	0.000389	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—JAG1—pancreatic cancer	2.9e-05	0.000389	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NOTCH3—pancreatic cancer	2.89e-05	0.000387	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AGTR1—pancreatic cancer	2.89e-05	0.000386	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—KRAS—pancreatic cancer	2.88e-05	0.000386	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—PIK3CD—pancreatic cancer	2.86e-05	0.000383	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—STK11—pancreatic cancer	2.85e-05	0.000381	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—STK11—pancreatic cancer	2.76e-05	0.00037	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SST—pancreatic cancer	2.76e-05	0.000369	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.75e-05	0.000368	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CNR1—pancreatic cancer	2.74e-05	0.000367	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.72e-05	0.000364	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—JAG1—pancreatic cancer	2.7e-05	0.000361	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—KRAS—pancreatic cancer	2.69e-05	0.00036	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NOTCH3—pancreatic cancer	2.69e-05	0.00036	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PIK3CD—pancreatic cancer	2.67e-05	0.000358	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SMAD4—pancreatic cancer	2.67e-05	0.000357	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PIK3CG—pancreatic cancer	2.66e-05	0.000356	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—PIK3CA—pancreatic cancer	2.65e-05	0.000355	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GCG—pancreatic cancer	2.65e-05	0.000354	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—SRC—pancreatic cancer	2.64e-05	0.000354	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CXCL8—pancreatic cancer	2.64e-05	0.000353	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HES1—pancreatic cancer	2.6e-05	0.000349	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—VEGFA—pancreatic cancer	2.57e-05	0.000344	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.57e-05	0.000344	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.57e-05	0.000343	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—TP53—pancreatic cancer	2.56e-05	0.000343	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CNR1—pancreatic cancer	2.54e-05	0.000341	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—NRAS—pancreatic cancer	2.54e-05	0.00034	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AGTR1—pancreatic cancer	2.52e-05	0.000338	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—PIK3CB—pancreatic cancer	2.49e-05	0.000334	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SMAD4—pancreatic cancer	2.49e-05	0.000333	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—STK11—pancreatic cancer	2.49e-05	0.000333	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—PIK3CA—pancreatic cancer	2.47e-05	0.000331	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PIK3CG—pancreatic cancer	2.47e-05	0.000331	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CXCL8—pancreatic cancer	2.47e-05	0.00033	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GCG—pancreatic cancer	2.46e-05	0.000329	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—HRAS—pancreatic cancer	2.45e-05	0.000328	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HES1—pancreatic cancer	2.43e-05	0.000326	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CXCL8—pancreatic cancer	2.4e-05	0.000321	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—TP53—pancreatic cancer	2.39e-05	0.00032	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.39e-05	0.00032	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—APOE—pancreatic cancer	2.38e-05	0.000319	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—TYMS—pancreatic cancer	2.38e-05	0.000318	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TGFB1—pancreatic cancer	2.36e-05	0.000316	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AGTR1—pancreatic cancer	2.34e-05	0.000314	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PIK3CD—pancreatic cancer	2.34e-05	0.000313	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PIK3CB—pancreatic cancer	2.33e-05	0.000312	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—STK11—pancreatic cancer	2.31e-05	0.000309	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—HRAS—pancreatic cancer	2.29e-05	0.000306	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TERT—pancreatic cancer	2.28e-05	0.000305	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.24e-05	0.0003	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CXCL8—pancreatic cancer	2.24e-05	0.0003	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—KRAS—pancreatic cancer	2.19e-05	0.000293	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HIF1A—pancreatic cancer	2.18e-05	0.000292	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SMAD4—pancreatic cancer	2.18e-05	0.000292	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TSC2—pancreatic cancer	2.18e-05	0.000291	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PIK3CD—pancreatic cancer	2.17e-05	0.000291	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—AKT1—pancreatic cancer	2.16e-05	0.00029	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CXCL8—pancreatic cancer	2.16e-05	0.000288	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3CG—pancreatic cancer	2.15e-05	0.000287	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TERT—pancreatic cancer	2.13e-05	0.000285	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APOE—pancreatic cancer	2.13e-05	0.000285	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HES1—pancreatic cancer	2.13e-05	0.000285	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—KDR—pancreatic cancer	2.09e-05	0.000279	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.08e-05	0.000279	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PPARG—pancreatic cancer	2.07e-05	0.000277	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HIF1A—pancreatic cancer	2.04e-05	0.000273	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PIK3CB—pancreatic cancer	2.04e-05	0.000273	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TSC2—pancreatic cancer	2.03e-05	0.000272	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SMAD4—pancreatic cancer	2.02e-05	0.000271	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—AKT1—pancreatic cancer	2.02e-05	0.000271	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—PIK3CA—pancreatic cancer	2.01e-05	0.000269	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	2e-05	0.000268	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APOE—pancreatic cancer	1.99e-05	0.000266	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NFKBIA—pancreatic cancer	1.99e-05	0.000266	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HES1—pancreatic cancer	1.98e-05	0.000264	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NOTCH1—pancreatic cancer	1.97e-05	0.000263	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CXCL8—pancreatic cancer	1.96e-05	0.000262	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—KDR—pancreatic cancer	1.95e-05	0.000261	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TP53—pancreatic cancer	1.94e-05	0.00026	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APOE—pancreatic cancer	1.93e-05	0.000259	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CG—pancreatic cancer	1.92e-05	0.000257	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—NRAS—pancreatic cancer	1.92e-05	0.000257	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EGF—pancreatic cancer	1.9e-05	0.000254	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.89e-05	0.000253	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3CD—pancreatic cancer	1.89e-05	0.000253	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	1.86e-05	0.000249	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—HRAS—pancreatic cancer	1.86e-05	0.000249	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NFKBIA—pancreatic cancer	1.85e-05	0.000248	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NOTCH1—pancreatic cancer	1.84e-05	0.000246	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CXCL8—pancreatic cancer	1.82e-05	0.000243	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CG—pancreatic cancer	1.8e-05	0.00024	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—NRAS—pancreatic cancer	1.8e-05	0.00024	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	1.78e-05	0.000239	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	1.78e-05	0.000238	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EGF—pancreatic cancer	1.78e-05	0.000238	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—EGFR—pancreatic cancer	1.75e-05	0.000234	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CG—pancreatic cancer	1.74e-05	0.000233	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	1.74e-05	0.000233	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TERT—pancreatic cancer	1.73e-05	0.000232	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	1.7e-05	0.000228	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CD—pancreatic cancer	1.69e-05	0.000226	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PPARG—pancreatic cancer	1.68e-05	0.000225	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.67e-05	0.000224	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HIF1A—pancreatic cancer	1.66e-05	0.000222	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—KRAS—pancreatic cancer	1.66e-05	0.000221	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TSC2—pancreatic cancer	1.65e-05	0.000221	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3CB—pancreatic cancer	1.65e-05	0.00022	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—AKT1—pancreatic cancer	1.64e-05	0.00022	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—EGFR—pancreatic cancer	1.64e-05	0.000219	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTGS2—pancreatic cancer	1.63e-05	0.000218	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	1.62e-05	0.000217	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOE—pancreatic cancer	1.62e-05	0.000216	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	1.61e-05	0.000215	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—KDR—pancreatic cancer	1.58e-05	0.000212	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CD—pancreatic cancer	1.58e-05	0.000211	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	1.57e-05	0.00021	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	1.57e-05	0.00021	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.56e-05	0.000209	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	1.55e-05	0.000208	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—KRAS—pancreatic cancer	1.55e-05	0.000207	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	1.53e-05	0.000205	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.52e-05	0.000203	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	1.51e-05	0.000202	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	1.49e-05	0.0002	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CB—pancreatic cancer	1.47e-05	0.000197	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	1.46e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	1.46e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	1.44e-05	0.000193	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	1.43e-05	0.000191	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTEN—pancreatic cancer	1.42e-05	0.00019	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PIK3CA—pancreatic cancer	1.42e-05	0.00019	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCL8—pancreatic cancer	1.42e-05	0.000189	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—HRAS—pancreatic cancer	1.41e-05	0.000188	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	1.38e-05	0.000185	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CB—pancreatic cancer	1.38e-05	0.000184	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—AKT1—pancreatic cancer	1.37e-05	0.000183	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.37e-05	0.000183	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CASP3—pancreatic cancer	1.36e-05	0.000181	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	1.35e-05	0.000181	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	1.34e-05	0.000179	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	1.33e-05	0.000178	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTGS2—pancreatic cancer	1.32e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCL8—pancreatic cancer	1.32e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	1.32e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—HRAS—pancreatic cancer	1.31e-05	0.000176	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	1.31e-05	0.000175	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	1.28e-05	0.000172	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	1.28e-05	0.000171	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—AKT1—pancreatic cancer	1.28e-05	0.000171	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	1.27e-05	0.00017	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.27e-05	0.00017	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CASP3—pancreatic cancer	1.27e-05	0.000169	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	1.26e-05	0.000168	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	1.24e-05	0.000166	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.24e-05	0.000166	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCND1—pancreatic cancer	1.23e-05	0.000165	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CTNNB1—pancreatic cancer	1.22e-05	0.000163	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	1.2e-05	0.000161	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MMP9—pancreatic cancer	1.2e-05	0.00016	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PTEN—pancreatic cancer	1.19e-05	0.000159	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	1.18e-05	0.000158	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—AKT1—pancreatic cancer	1.16e-05	0.000155	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	1.16e-05	0.000155	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTEN—pancreatic cancer	1.16e-05	0.000155	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.15e-05	0.000154	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	1.15e-05	0.000154	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	1.15e-05	0.000154	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	1.14e-05	0.000152	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	1.14e-05	0.000152	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	1.12e-05	0.00015	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	1.12e-05	0.000149	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	1.11e-05	0.000148	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SRC—pancreatic cancer	1.1e-05	0.000148	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	1.08e-05	0.000144	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	1.07e-05	0.000144	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	1.07e-05	0.000144	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	1.07e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.07e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	1.06e-05	0.000142	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	1.06e-05	0.000142	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	1.06e-05	0.000142	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	1.06e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	1.05e-05	0.00014	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	1.04e-05	0.000139	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.04e-05	0.000139	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	1.03e-05	0.000138	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	1.03e-05	0.000138	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	1.01e-05	0.000136	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	1e-05	0.000134	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	1e-05	0.000134	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	9.91e-06	0.000133	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	9.88e-06	0.000132	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	9.86e-06	0.000132	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	9.78e-06	0.000131	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	9.72e-06	0.00013	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	9.67e-06	0.000129	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	9.66e-06	0.000129	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	9.64e-06	0.000129	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	9.42e-06	0.000126	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	9.39e-06	0.000126	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	9.3e-06	0.000124	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	9.28e-06	0.000124	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	9.13e-06	0.000122	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	8.98e-06	0.00012	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	8.96e-06	0.00012	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	8.73e-06	0.000117	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	8.69e-06	0.000116	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	8.64e-06	0.000116	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	8.64e-06	0.000116	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	8.62e-06	0.000115	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	8.62e-06	0.000115	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	8.45e-06	0.000113	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	8.39e-06	0.000112	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	8.31e-06	0.000111	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—AKT1—pancreatic cancer	8.2e-06	0.00011	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	8.15e-06	0.000109	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	8.12e-06	0.000109	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	8.03e-06	0.000107	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	8.01e-06	0.000107	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	7.98e-06	0.000107	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	7.85e-06	0.000105	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	7.76e-06	0.000104	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	7.42e-06	9.93e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	7.34e-06	9.82e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	7.33e-06	9.82e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	7.1e-06	9.5e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	6.85e-06	9.17e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	6.82e-06	9.12e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	6.79e-06	9.08e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AKT1—pancreatic cancer	6.66e-06	8.91e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	6.59e-06	8.82e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	6.31e-06	8.44e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	5.99e-06	8.02e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	5.57e-06	7.45e-05	CbGpPWpGaD
